lancet semaglutide tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide vs. Semaglutide: Which is – GLP-1 prevention of heart disease

So, how much water do you actually need to drink

*Based on manufacturer trials of the 7.2 mg dose in adults with obesity alongside diet and exercise (vs ~4% with diet and exercise alone)

Less common but more serious risks include pancreatitis, gallbladder disease, hypoglycemia (when used with insulin or sulfonylureas), kidney injury (with severe dehydration), and retinopathy worsening in patients with pre-existing diabetic retinopathy

Q: Does injecting Wegovy in a specific site reduce nausea

The effects of GLP-1 receptor agonists on inhibition of food intake and body weight loss are currently of considerable interest (118)